1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Furukawa, K.
Oda, M.
Nakamura, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
93
13583
13588
10.1073/pnas.93.24.13583
8942977
A small engineered protein lacks structural uniqueness by increasing the side-chain conformational entropy.
1996
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
2
309
Comparison of the Free and DNA-Complexed Forms of the DNA-Binding Domain from C-Myb
1995
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
79
639
Solution Structure of a Specific DNA Complex of the Myb DNA-Binding Domain with Cooperative Recognition Helices
1994
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
89
6428
Solution Structure of a DNA-Binding Unit of Myb: A Helix-Turn-Helix-Related Motif with Conserved Tryptophans Forming a Hydrophobic Core
1992
10.2210/pdb1idz/pdb
pdb_00001idz
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6521.496
MOUSE C-MYB DNA-BINDING DOMAIN REPEAT 3
P140M, I155L
1
man
polymer
no
no
MEVKKTSWTEEEDRILYQAHKRLGNRWAEIAKLLPGRTDNAIKNHWNSTMRRKV
MEVKKTSWTEEEDRILYQAHKRLGNRWAEIAKLLPGRTDNAIKNHWNSTMRRKV
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
house mouse
Mus
Escherichia
sample
10090
Mus musculus
562
Escherichia coli
PAR2156NCOI
PRP3
database_2
pdbx_database_related
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_keywords
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Structure summary
1
0
1996-12-23
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_related.content_type
_pdbx_database_related.details
_pdbx_database_status.process_site
_struct_keywords.text
_struct_ref_seq_dif.details
representative structure
Y
BNL
1996-08-15
REL
0.1 ANGSTROM MAXIMUM DISTANCE VIOLATION
120
20
2D 1H-1H NOESY
5.0
283
K
SIMULATED ANNEALING IN 4D
MORIKAMI,NAKAI,KIDERA,SAITO,NAKAMURA
refinement
PRESTO
structure solution
EMBOSS
600.13
Bruker
AMX-600
MET
140
n
1
MET
140
A
GLU
141
n
2
GLU
141
A
VAL
142
n
3
VAL
142
A
LYS
143
n
4
LYS
143
A
LYS
144
n
5
LYS
144
A
THR
145
n
6
THR
145
A
SER
146
n
7
SER
146
A
TRP
147
n
8
TRP
147
A
THR
148
n
9
THR
148
A
GLU
149
n
10
GLU
149
A
GLU
150
n
11
GLU
150
A
GLU
151
n
12
GLU
151
A
ASP
152
n
13
ASP
152
A
ARG
153
n
14
ARG
153
A
ILE
154
n
15
ILE
154
A
LEU
155
n
16
LEU
155
A
TYR
156
n
17
TYR
156
A
GLN
157
n
18
GLN
157
A
ALA
158
n
19
ALA
158
A
HIS
159
n
20
HIS
159
A
LYS
160
n
21
LYS
160
A
ARG
161
n
22
ARG
161
A
LEU
162
n
23
LEU
162
A
GLY
163
n
24
GLY
163
A
ASN
164
n
25
ASN
164
A
ARG
165
n
26
ARG
165
A
TRP
166
n
27
TRP
166
A
ALA
167
n
28
ALA
167
A
GLU
168
n
29
GLU
168
A
ILE
169
n
30
ILE
169
A
ALA
170
n
31
ALA
170
A
LYS
171
n
32
LYS
171
A
LEU
172
n
33
LEU
172
A
LEU
173
n
34
LEU
173
A
PRO
174
n
35
PRO
174
A
GLY
175
n
36
GLY
175
A
ARG
176
n
37
ARG
176
A
THR
177
n
38
THR
177
A
ASP
178
n
39
ASP
178
A
ASN
179
n
40
ASN
179
A
ALA
180
n
41
ALA
180
A
ILE
181
n
42
ILE
181
A
LYS
182
n
43
LYS
182
A
ASN
183
n
44
ASN
183
A
HIS
184
n
45
HIS
184
A
TRP
185
n
46
TRP
185
A
ASN
186
n
47
ASN
186
A
SER
187
n
48
SER
187
A
THR
188
n
49
THR
188
A
MET
189
n
50
MET
189
A
ARG
190
n
51
ARG
190
A
ARG
191
n
52
ARG
191
A
LYS
192
n
53
LYS
192
A
VAL
193
n
54
VAL
193
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
12
A
ARG
153
0.092
SIDE CHAIN
1
A
GLU
141
-156.17
47.52
1
A
LYS
143
69.57
-69.78
1
A
ASN
164
-160.76
22.33
1
A
LYS
192
67.03
90.39
2
A
LYS
143
-177.90
-43.54
2
A
ASN
164
-83.19
30.91
3
A
VAL
142
36.95
-124.85
3
A
LYS
143
28.75
59.97
3
A
SER
146
73.25
119.09
3
A
ASN
164
-160.57
22.30
3
A
LYS
192
59.75
105.47
4
A
LYS
143
-140.28
-23.77
4
A
SER
146
-150.73
35.81
4
A
ASN
164
-81.56
45.07
4
A
ARG
165
-102.27
69.97
4
A
THR
188
-104.99
-61.06
5
A
VAL
142
-137.98
-41.81
5
A
LYS
143
-164.22
102.60
5
A
SER
146
-162.30
65.83
5
A
ALA
167
-50.74
-71.66
5
A
THR
188
-104.09
-69.84
6
A
VAL
142
48.12
-177.13
6
A
LYS
143
51.06
-160.51
6
A
LYS
144
-91.06
32.50
6
A
THR
188
-157.33
-39.36
6
A
ARG
190
62.27
100.77
7
A
GLU
141
62.36
92.41
7
A
LYS
143
38.55
51.86
7
A
ASN
164
-160.35
25.05
7
A
ARG
176
57.32
-176.90
7
A
THR
188
-79.24
-77.46
7
A
LYS
192
56.54
82.91
8
A
VAL
142
39.14
46.42
8
A
LYS
143
39.75
41.18
8
A
THR
188
-82.36
-70.67
9
A
LYS
143
-84.02
-70.35
9
A
LYS
144
-90.10
52.94
9
A
ASN
164
-79.95
28.05
9
A
SER
187
-79.29
-82.39
9
A
MET
189
-172.78
-40.27
10
A
GLU
141
66.76
-72.75
10
A
VAL
142
62.98
175.92
10
A
LYS
143
85.32
-31.43
10
A
SER
146
-66.35
-75.37
10
A
TRP
166
-77.39
35.93
10
A
SER
187
-84.54
35.89
10
A
THR
188
-160.38
-33.43
10
A
ARG
191
63.62
-176.07
11
A
THR
145
-66.20
88.83
11
A
ASP
152
-124.38
-51.39
11
A
ARG
165
-114.43
66.09
11
A
THR
188
-137.78
-66.73
11
A
MET
189
-66.99
-76.21
11
A
ARG
191
71.47
175.01
11
A
LYS
192
60.89
74.79
12
A
LYS
143
-160.01
-49.82
12
A
SER
146
-87.05
-154.95
12
A
TRP
166
-74.79
37.75
12
A
ALA
167
-91.14
-69.44
12
A
ARG
191
70.12
-61.20
13
A
THR
188
-105.81
-74.17
13
A
ARG
191
-159.45
-67.81
13
A
LYS
192
-173.28
-67.80
14
A
GLU
141
48.71
74.68
14
A
THR
145
-68.17
92.56
14
A
ASN
164
-160.89
21.40
14
A
SER
187
-90.44
-63.02
14
A
MET
189
-81.43
46.96
14
A
ARG
190
-179.97
60.84
15
A
ASN
164
-160.49
23.79
15
A
SER
187
-86.88
31.71
15
A
THR
188
-156.04
-60.54
15
A
LYS
192
79.57
-49.53
16
A
GLU
141
74.35
-61.82
16
A
VAL
142
-59.66
-73.62
16
A
LYS
143
74.88
-48.12
16
A
LYS
144
-59.42
103.58
16
A
SER
146
77.23
151.89
16
A
THR
188
-92.23
-61.40
16
A
ARG
190
-101.72
57.08
16
A
LYS
192
-103.89
45.64
17
A
ARG
161
-90.69
-62.87
17
A
ASN
164
-82.11
49.81
17
A
ARG
165
-112.25
61.60
17
A
ASN
186
-90.61
-60.71
17
A
LYS
192
-140.78
-69.84
18
A
SER
146
-68.29
91.10
18
A
ALA
170
-80.61
42.65
18
A
PRO
174
-69.32
82.57
18
A
ARG
176
56.23
92.38
18
A
THR
188
-110.23
61.98
18
A
MET
189
-176.63
-42.57
18
A
LYS
192
-142.00
-66.42
19
A
THR
145
-84.88
35.44
19
A
THR
188
-149.98
55.18
19
A
MET
189
-171.34
49.85
19
A
ARG
191
-52.14
108.98
20
A
GLU
141
-111.50
-114.69
20
A
SER
146
-80.22
36.41
20
A
ASN
164
-161.27
21.52
20
A
THR
188
-80.90
-94.26
20
A
ARG
191
64.12
178.23
20
A
LYS
192
73.56
-66.58
refinement
AMBER
STRUCTURE OF MYB TRANSFORMING PROTEIN, NMR, 20 STRUCTURES
1
Y
N
A
GLU
149
A
GLU
10
HELX_P
A
LEU
162
A
LEU
23
1
1
14
A
TRP
166
A
TRP
27
HELX_P
A
LEU
172
A
LEU
33
1
2
7
A
ASP
178
A
ASP
39
HELX_P
A
SER
187
A
SER
48
1
3
10
DNA BINDING PROTEIN
PROTOONCOGENE PRODUCT, DNA-BINDING PROTEIN, DNA BINDING PROTEIN
MYB_MOUSE
UNP
1
1
P06876
MARRPRHSIYSSDEDDEDIEMCDHDYDGLLPKSGKRHLGKTRWTREEDEKLKKLVEQNGTDDWKVIANYLPNRTDVQCQH
RWQKVLNPELIKGPWTKEEDQRVIELVQKYGPKRWSVIAKHLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHK
RLGNRWAEIAKLLPGRTDNAIKNHWNSTMRRKVEQEGYLQEPSKASQTPVATSFQKNNHLMGFGHASPPSQLSPSGQSSV
NSEYPYYHIAEAQNISSHVPYPVALHVNIVNVPQPAAAAIQRHYNDEDPEKEKRIKELELLLMSTENELKGQQALPTQNH
TCSYPGWHSTSIVDQTRPHGDSAPVSCLGEHHATPSLPADPGSLPEESASPARCMIVHQGTILDNVKNLLEFAETLQFID
SFLNTSSNHESSGLDAPTLPSTPLIGHKLTPCRDQTVKTQKENSIFRTPAIKRSILESSPRTPTPFKHALAAQEIKYGPL
KMLPQTPSHAVEDLQDVIKRESDESGIVAEFQESGPPLLKKIKQEVESPTEKSGNFFCSNHWAENSLSTQLFSQASPVAD
APNILTSSVLMTPVSEDEDNVLKAFTVPKNRPLVGPLQPCSGAWEPASCGKTEDQMTASGPARKYVNAFSARTLVM
141
193
1IDZ
141
193
P06876
A
1
2
54
1
ILE
engineered mutation
LEU
155
1IDZ
A
P06876
UNP
155
16
1
P 1